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CAS E R E PORT
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Abstract
Chest irradiation is associated with numerous early and late complications that arise from ionizing radiation-induced damage
to cellular structures within the field of therapy. In patients exposed to chest irradiation at an early age as part of the treatment
of childhood cancer, specifically Hodgkin’s lymphoma, the increased risk of breast cancer in the long run should be considered.
A case of a 35-year-old woman who exposed to chest irradiation as part of the treatment of Hodgkin’s lymphoma at the age of
20 years is presented here and serves as a reminder of this somewhat overlooked complication. The article presents the evidence
available for and against breast cancer screening in this particular patient population.
INTRODUCTION
It has long been established that young women treated for child-
hood cancer, specifically Hodgkin’s lymphoma, with chest irradi-
ation have an elevated risk of breast cancer [1–4]. On the basis of
this, guidelines have been put in place regarding breast imaging
for early detection of cancer in patients exposed to chest irradi-
ation. Awareness of these guidelines and strength of evidence
are essential in the primary care setting to guide appropriate
management. We report a case of radiation-induced breast can-
cer in a young woman and summarize the available evidence
that pertains to screening in this patient population.
CASE REPORT
A 35-year-old woman presented to the primary care clinic to es-
tablish care after relocating to a new city. She reported intermit-
tent, unilateral, bloody nipple discharge over the preceding
2months, and the presence of a breastmass. She denied overlying
skin changes or abnormalities in the contralateral breast. Her
past history was significant for Hodgkin lymphoma (HL) diag-
nosed when she was 20 years old, and treated with combination
chemotherapy (ABVD; doxorubicin, bleomycin, vinblastine and
dacarbazine) and chest radiation therapy (RT). There was no evi-
dence of disease recurrence over the 15-year period of follow-up,
and the patient was deemed cured. She denied tobacco or illicit
drug use. Her family history was negative for malignancy,
and she was not taking any prescription or over-the-counter
medications.
Clinical breast examination revealed a small palpablemass in
the right breast at the 10 o’clock position. Therewas no nipple re-
traction or skin discoloration. Examination of the left breast and
axillary lymph nodes was unremarkable. The patient underwent
bilateral mammography and an ultrasound of the right breast
which confirmed the presence of a suspicious mass measuring
0.8 × 0.7 cm at the same position ∼2 cm from the nipple. Image-
guided core biopsy revealed moderately differentiated invasive
ductal adenocarcinoma. Estrogen receptor was strongly positive
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in 90% of tumor cells, progesterone receptor was positive in 50%
of tumor cells and HER2was scored as 0 by immunohistochemis-
try (IHC). The patient underwent a modified radical mastectomy
after sentinel lymph node sampling was negative for malig-
nancy. Her clinical stagewas IA, and shewas started on adjuvant
hormonal therapy with tamoxifen for a planned 5-year period.
Genetic testing for BRCA 1 and BRCA 2 mutations was negative.
DISCUSSION
Being aware of the guidelines pertaining to long-term healthcare
of cancer survivors is essential when dealing with patients in the
primary care setting. Evidence-based guidelines on routine
breast imaging for early detection of treatment-related breast
cancer is one such area that tends to be missed by patients and
primary care physicians due to their unfamiliarity with the rec-
ommendation. A survey of women in Canada and the USA trea-
tedwith chest RT in the pediatric age revealed that only 49%were
aware of the increased risk of breast cancer [5].
The risk is highest in younger patients (<30 years) exposed to
extended-field RT that targeted the axillae, infraclavicular, hilar
and mediastinal nodes (i.e. mantle). The Late Effects Study
Group trial reported a 56.7-fold increase in the overall risk of
breast cancer associated with prior mantle RT at a young age
compared with the general population. In that study, the relative
risk according to the follow-up interval was 0 at 5–9 years, 71.3 at
10–14 years and 90.8 at 15–19 years [4]. Since then, mantle RT has
been replaced by involved-site and involved-field RT which is
associated with a significant decrease in the risk of direct breast
irradiation [6].
Despite the current use of targeted RT, there are still survivors
who received outdated RTandwhowill require screening for dec-
ades to come. The Society of Breast Imaging, American College of
Radiology (ACR) [7] and the National Comprehensive Cancer Net-
work (NCCN) [8] recommend annual mammogram screening to-
gether with breast MRI for women who underwent chest RT
between the ages of 10 and 30 years beginning 8–10 years after ex-
posure. However, breast mammogram is not recommended for
women <25 years of age. The addition of breast MRI is also recom-
mendedby theAmericanCancer Society (ACS) due to the improved
sensitivity seenwith combining the twomodalities [9]. A prospect-
ive study inHL survivors showed equal sensitivityof bothmethods
(68% for mammography and 63% for MRI), but reported a remark-
able improvement insensitivitywith the combination (95%),which
allowed for detection of early-stage breast cancer [10].
Our patient was not aware of her need for breast cancer
screening starting at age 28–30, and the diagnosis came as a sur-
prise to her. Given her negative family history for breast cancer
and lack of high-risk genetic mutations, it would be reasonable
to conclude that thiswas radiation-induced breast cancer. Lump-
ectomy followed by RTwas not an option due to her previous his-
tory of chest RT. Furthermore, had it not been an early-stage
tumor, she would have required systemic chemotherapy that in-
cluded a second round of anthracycline-based treatments put-
ting her at greater risk of cardiomyopathy.
It is important to recognize that all these recommendations are
based on expert consensus opinion and are supported by neither
nonrandomized observational studies nor prospective rando-
mized trials. These guidelines have been put in place because of
the evidence for increased lifetime risk of breast cancer in this pa-
tient population. Unfortunately, strong evidence in support of
screening is likely unachievable due to the limited population
size. The risks associated with screening, such as the high rate
of false-positive results leading to unnecessary interventions
andpsychological distress, should be considered in counseling pa-
tients in the primary care setting. It remains a matter of opinion
whether early detection in this group outweighs the risks and
whether it leads to improvement in survival.
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